Molecular Imaging in Targeted Therapeutics

With the rapid development of precision medicine, targeted therapy of tumors has made great advances. However, tumors of the same type were found to harbor difierent molecular alterations such as specific receptor, transporter, and cell expression levels before and even during the targeted therapy. Molecular imaging allows mapping of disease markers in vivo and understanding of disease biology. It promotes targeted therapy by therapeutic efiect prediction, early response evaluation, and therapeutic regimen determination in preclinical and clinical settings. Molecular imaging technologies are being recognized as one of the most valuable tools in the field of precision medicine, which will make individual treatment decisions for better patient outcome care.